Glimyes-PM1 SR

Glimyes-PM1 SR Tablets

Composition:

• Metformin Hydrochloride (SR)
• Glimepiride – 1 mg
• Pioglitazone Hydrochloride

Description:

Glimyes-PM1 SR is a triple-combination anti-diabetic medication designed for effective management of Type 2 Diabetes Mellitus. It provides comprehensive glycemic control by targeting insulin secretion, insulin sensitivity, and glucose production.

Uses:

• Type 2 Diabetes Mellitus
• Poorly controlled blood sugar with dual therapy
• Improves insulin sensitivity and glucose utilization

Mechanism of Action:

• Glimepiride increases insulin secretion from pancreas
• Metformin (SR) reduces hepatic glucose production and improves insulin sensitivity
• Pioglitazone enhances peripheral glucose uptake by improving insulin sensitivity

Dosage:

• As prescribed by the physician
• Usually once daily with meals
• Regular monitoring of blood sugar required

Side Effects:

Common:

• Weight gain
• Edema (fluid retention)
• Hypoglycemia
• Nausea

Serious (rare):

• Heart failure risk (pioglitazone-related)
• Lactic acidosis
• Liver dysfunction

Precautions:

• Avoid in heart failure patients
• Monitor liver function
• Avoid alcohol
• Use cautiously in kidney/liver impairment
• Take with food